Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia: A report from the BINGO study

Published 2010 View Full Article

Authors

Keywords

Journal

CANCER SCIENCE

Volume 101, Issue 10, Pages 2186-2192

Publisher

Wiley

Online

2010-06-10

DOI

10.1111/j.1349-7006.2010.01643.x

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

CANCER SCIENCE

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Become a Peeref-certified reviewer